Susceptibility to pancreatic ductal adenocarcinoma (PDAC) may be conferred by mutation in RABL3. Other cancers, including melanoma, breast cancer, and colon cancer, have been reported in RABL3 mutation-carrying individuals, with or without PDAC (Nissim et al., 2019).
For background, phenotypic description, and a discussion of genetic heterogeneity of pancreatic carcinoma, see 260350. [from
OMIM]